A European chemical industry group has reiterated that gelatin is safe after Indian regulators called for feedback on a plan to replace the excipient with cellulose in pharmaceutical capsules.
The pharmaceutical industry must change its ingredients and manufacturing methods to cash in on the enormous purchasing power of European Muslims, says an expert.
Aoxing Pharmaceuticals reported increased sales and lower operating expenses for Q2 2013 one year on from the chromatin-tainted gelatin scandal that led to suspension of sales by China’s regulators.
Biostar Pharmaceuticals has blamed end-of-year losses on last year’s chromium-tainted gelatin scandal though it is slowly recovering following a suspension of sales enforced by the SFDA.
From July the EC will require that gelatin used in parenteral drugs is sourced from countries in World Organisation for Animal Health's (OIE) lowest risk categories for bovine spongiform encephalopathy (BSE).
US raw materials supplier Originates has boosted its pharmaceutical bovine hide gelatin manufacturing capacity with the addition of two new ISO 9000/9001 certified, GMP-standard production facilities in South America.
Cerestar has responded to the rising demand for starch-based
excipients by extending its range of Sorbitol products, two
non-animal and non-synthetic based formulations that offers a
carrier platform for active pharmaceutical ingredients.
Encapsulation specialist RP Scherer, part of the Cardinal Health
group, has been granted a patent on a technology that could be used
to reduce the amount of flavours and sweeteners used in
fast-dispersing dosage forms.
